Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response - DEMETER Trial A Phase II Clinical Study to Investigate the Efficacy of Dexamethasone as an Adjunct to Endocrine Therapy in ER+, HER2- Metastatic Breast Cancer.

NCT07786051 is registered in ClinicalTrials.gov with The Netherlands Cancer Institute as lead sponsor.

NCT NCT07786051
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07786051 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
DiEtary Mimicry by Glucocorticoid Modulation Evaluation in ER+ Metastatic Breast Cancer Treatment: Efficacy and Response - DEMETER Trial A Phase II Clinical Study to Investigate the Efficacy of Dexamethasone as an Adjunct to Endocrine Therapy in ER+, HER2- Metastatic Breast Cancer.
Lead sponsor
The Netherlands Cancer Institute
Phase
Phase 2
Overall status
Not yet recruiting
Start date
November 1, 2026
Completion date
November 1, 2028
Enrollment
80 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer